Janus-faced liposomes enhance antimicrobial innate immune response in <i>Mycobacterium tuberculosis</i> infection
Emanuela Greco(University of Rome Tor Vergata), Maurizio Fraziano(University of Rome Tor Vergata), Loredana Sarmati(University of Rome Tor Vergata), Mario Giuseppe Alma(Carlo Forlanini Hospital), Nigel D. L. Savage(Leiden University Medical Center), Roberto Nisini(Centro di Ricerca per la Patologia Vegetale), Angelo Martino(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Cinzia Marcantonio(Istituto Superiore di Sanità), Marco De Spirito(Università Cattolica del Sacro Cuore), Annalucia Serafino(Istituto di Farmacologia Traslazionale), Anna Rita Ciccaglione(Istituto Superiore di Sanità), Delia Goletti(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Giovanni Delogu(Università Cattolica del Sacro Cuore), Massimo Andreoni(University of Rome Tor Vergata), Diana Di Liberto(University of Palermo), Giuseppe Maulucci(Università Cattolica del Sacro Cuore), Massimiliano Papi(Università Cattolica del Sacro Cuore), Nadia Caccamo(University of Palermo), Marilina B. Santucci(University of Rome Tor Vergata), Gianluca Quintiliani(University of Rome Tor Vergata), Tom H. M. Ottenhoff(Office of Infectious Diseases), A Altieri(Carlo Forlanini Hospital), Francesco Dieli(University of Palermo)
Cited by 63
Related Papers
Guidelines for the use of flow cytometry and cell sorting in immunological studies <sup>*</sup>
|European Journal of Immunology|2017|554
The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination
|Nature|2001|464
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
|Journal of Infection|2020|445
Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans
|Human Immunology|2004|413